VIKING THERAPEUTICS INC (VKTX) Stock Analyst Earnings Estimates
NASDAQ:VKTX - Nasdaq - US92686J1060 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 338.60% | N/A 230.45% | N/A 666.61% | N/A 324.02% | N/A 127.83% | N/A 60.81% | N/A 38.47% | ||||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A -21.76% | N/A -30.72% | N/A -38.37% | N/A -17.68% | -100.535M -45.16% | -150.575M -49.77% | N/A -46.00% | N/A -34.39% | N/A -25.94% | N/A -14.27% | N/A 16.29% | N/A 150.34% | N/A 286.87% | N/A 94.78% | |
| EBIT YoY % growth | -23.47M | -12M 48.87% | -13.85M -15.42% | -19.07M -37.69% | -26.16M -37.18% | -32.69M -24.96% | -42.66M -30.50% | -55.68M -30.52% | -70.36M -26.36% | -100.827M -43.30% | -150.921M -49.68% | N/A -63.58% | N/A -31.11% | N/A -21.30% | N/A -5.04% | N/A 40.56% | N/A 253.46% | N/A 171.13% | N/A 76.08% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -3.56 | -1.00 71.91% | -0.80 20.00% | -0.39 51.25% | -0.36 7.69% | -0.54 -50.00% | -0.72 -33.33% | -0.91 -26.39% | -0.92 -1.10% | -1.00 -8.70% | N/A -92.69% | N/A -35.94% | N/A -16.09% | N/A 11.11% | N/A 60.82% | N/A 372.72% | N/A 184.00% | N/A 63.09% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.67 -205.42% | -0.71 -123.36% | -0.66 -61.29% | -0.56 3.28% | -0.62 8.41% | -0.66 7.24% | -0.49 25.96% | -0.61 -9.09% | -0.67 -9.39% | -0.69 -4.62% |
| Revenue Q2Q % growth | 1.594M | -100.00% | N/A | N/A | N/A | N/A | ||||
| EBITDA Q2Q % growth | -70.896M -95.20% | -75.216M -63.90% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -80.202M -119.39% | -86.004M -86.00% | -86.108M -55.24% | -78.846M -5.73% | -87.414M -8.99% | -96.237M -11.90% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.58 -190.00% | -0.46 | -0.12 | -27.37% |
| Q1 2025 Q2Q % growth | -0.41 -57.69% | -0.33 | -0.08 | -23.91% |
| Q4 2024 Q2Q % growth | -0.32 -28.00% | -0.28 | -0.04 | -13.70% |
| Q3 2024 Q2Q % growth | -0.22 4.35% | -0.26 | 0.04 | 14.36% |
| Q2 2024 Q2Q % growth | -0.20 -5.26% | -0.28 | 0.08 | 27.38% |
| Q1 2024 Q2Q % growth | -0.26 -4.00% | -0.28 | 0.02 | 8.31% |
| Q4 2023 Q2Q % growth | -0.25 3.85% | -0.26 | 0.01 | 3.25% |
| Q3 2023 Q2Q % growth | -0.23 -9.52% | -0.22 | -0.01 | -2.92% |
| Q2 2023 Q2Q % growth | -0.19 17.39% | -0.20 | 0.01 | 3.16% |
| Q1 2023 Q2Q % growth | -0.25 -19.05% | -0.24 | -0.01 | -2.12% |
| Q4 2022 Q2Q % growth | -0.26 -62.50% | -0.24 | -0.02 | -9.97% |
| Q3 2022 Q2Q % growth | -0.21 -23.53% | -0.24 | 0.03 | 10.87% |
| Q2 2022 Q2Q % growth | -0.23 -15.00% | -0.22 | -0.01 | -6.36% |
| Q1 2022 Q2Q % growth | -0.21 -10.53% | -0.20 | -0.01 | -5.88% |
| Q4 2021 Q2Q % growth | -0.16 -6.67% | -0.19 | 0.03 | 16.46% |
| Q3 2021 Q2Q % growth | -0.17 -30.77% | -0.21 | 0.04 | 19.48% |
| Q2 2021 Q2Q % growth | -0.20 -53.85% | -0.20 | 0.00 | 0.78% |
| Q1 2021 Q2Q % growth | -0.19 -46.15% | -0.18 | -0.01 | -7.14% |
| Q4 2020 Q2Q % growth | -0.15 -50.00% | -0.16 | 0.01 | 3.59% |
| Q3 2020 Q2Q % growth | -0.13 -62.50% | -0.15 | 0.02 | 16.04% |
| Q2 2020 Q2Q % growth | -0.13 -18.18% | -0.15 | 0.02 | 10.92% |
| Q1 2020 Q2Q % growth | -0.13 -85.71% | -0.12 | -0.01 | -4.93% |
| Q4 2019 Q2Q % growth | -0.10 | -0.13 | 0.03 | 23.45% |
| Q3 2019 Q2Q % growth | -0.08 | -0.13 | 0.05 | 37.84% |
| Q2 2019 Q2Q % growth | -0.11 | -0.09 | -0.02 | -19.83% |
| Q1 2019 Q2Q % growth | -0.07 | -0.09 | 0.02 | 19.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.38% | -15.4% | 0% | -20.18% |
| Revenue | N/A | N/A | 0% | 0% |